Cytel is a leader in providing state-of-the-art statistical genetics and statistical genomics capabilities and methodologies to researchers seeking to uncover specific genetic components of complex human disorders and quantitative traits, as well as to advance new and enhanced drugs and diagnostics.
Interpreting the complex data sets generated by advanced genomic technologies—particularly next-generation sequencing—is intrinsically statistical. Axio offers a comprehensive range of statistical genetics and genomics research services to pharmaceutical and biotechnology companies, diagnostic companies, and academic and government laboratories focused on drug discovery and development, drug repositioning, and companion diagnostics development.
Using a unique interdisciplinary approach that merges deep experience in statistical genetics, bioinformatics, and biostatistics with clinical understanding, our highly trained PhD/MS staff apply state-of-the-art statistical genetics and computational methods to support researchers focused on experimental design, analysis, and interpretation of high-throughput genomic data.
Axio’s Statistical Genetics and Genomics services include:
- Power & sample size analysis
- Genetic data analysis
- Gene set enrichment analysis (GSEA)
- Genomic data analysis
- Diagnostic Development